AbstractBloodstream infections (BSI) are a major cause of mortality, morbidity and medical cost, but few population-based studies have concomitantly evaluated BSI incidence and mortality. Data on BSI episodes reported to national, population-based surveillance by all clinical microbiology laboratories in Finland during 2004–07 were linked to vital statistics. Age-, sex and microbe-specific incidence and mortality rates were calculated. During 2004–07, 33 473 BSI episodes were identified; BSI incidence increased from 147 to 168 per 100 000 population (average annual increase, 4.4%; p <0.001). Rates were highest among persons ≥65 years and <1 year, and higher among male patients than female patients (166 versus 152 per 100 000). The most comm...
BACKGROUND Bloodstream infections are often associated with significant mortality and morbidity. ...
Bloodstream infection (BSI) is associated with major morbidity and mortality. Population-based studi...
Few studies covering all patient groups and specialties are available regarding the outcome of nosoc...
AbstractBloodstream infections (BSI) are a major cause of mortality, morbidity and medical cost, but...
AbstractBloodstream infections (BSI) are a major cause of mortality, morbidity and medical cost, but...
We evaluated the incidence, outcomes, and causative agents of bloodstream infections (BSI) in Finlan...
Background: Studies from several countries indicate that the incidence and mortality of bloodstream ...
AbstractIn this systematic review, we estimated the total number of episodes of bloodstream infectio...
Background: Escherichia coli is the most common cause of bloodstream infections (BSIs) and mortality...
we assessed the incidence, risk factors and outcome of BSI over a 14-year period (2000-2013) in a Sw...
BackgroundBloodstream infections (BSI) are a public health concern, and infections caused by resista...
Background: Bloodstream infections (BSI) cause substantial morbidity and mortality. Aim: We explored...
we assessed the incidence, risk factors and outcome of BSI over a 14-year period (2000–2013) in a Sw...
Objectives: we assessed the incidence, risk factors and outcome of BSI over a 14-year period (2000-2...
Background: Escherichia coli is the most common cause of bloodstream infections (BSIs) and mortality...
BACKGROUND Bloodstream infections are often associated with significant mortality and morbidity. ...
Bloodstream infection (BSI) is associated with major morbidity and mortality. Population-based studi...
Few studies covering all patient groups and specialties are available regarding the outcome of nosoc...
AbstractBloodstream infections (BSI) are a major cause of mortality, morbidity and medical cost, but...
AbstractBloodstream infections (BSI) are a major cause of mortality, morbidity and medical cost, but...
We evaluated the incidence, outcomes, and causative agents of bloodstream infections (BSI) in Finlan...
Background: Studies from several countries indicate that the incidence and mortality of bloodstream ...
AbstractIn this systematic review, we estimated the total number of episodes of bloodstream infectio...
Background: Escherichia coli is the most common cause of bloodstream infections (BSIs) and mortality...
we assessed the incidence, risk factors and outcome of BSI over a 14-year period (2000-2013) in a Sw...
BackgroundBloodstream infections (BSI) are a public health concern, and infections caused by resista...
Background: Bloodstream infections (BSI) cause substantial morbidity and mortality. Aim: We explored...
we assessed the incidence, risk factors and outcome of BSI over a 14-year period (2000–2013) in a Sw...
Objectives: we assessed the incidence, risk factors and outcome of BSI over a 14-year period (2000-2...
Background: Escherichia coli is the most common cause of bloodstream infections (BSIs) and mortality...
BACKGROUND Bloodstream infections are often associated with significant mortality and morbidity. ...
Bloodstream infection (BSI) is associated with major morbidity and mortality. Population-based studi...
Few studies covering all patient groups and specialties are available regarding the outcome of nosoc...